loader2
Partner With Us NRI

Ami Organics Ltd share Price Today

Company details

1,280.70
1,326.50
1,004.45
1,388.95
6M Return 15.15%
1Y Return 0.84%
Mkt Cap.(Cr) 4,939.66
Volume 194,234
Div Yield 0.23%
OI
-
OI Chg %
-
Volume 194,234

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Technical Outlook
    Chemical stocks has been in limelight since beginning of April after being out of favour for several months as risk-reward turned favourable. Within the small cap Chemical stocks we remain constructive of Ami Organics as it has generated a breakout above the last 16 month range (₹1110-825) offering fresh entry opportunity

    The stock post its quarterly numbers has also generated a breakout above the bullish Flag formation with strong volume of more than six times the 50 days average volume of 0.78 lakhs share per day highlighting larger participation at the breakout area and continuation of the up move

    Structurally, it has witnessed a faster retracement of the last falling segment as 28 weeks decline (₹1154-861) was completely retraced in just eight weeks. A faster retracement signal a robust price structure

    We expect the stock to head towards ₹ 1290 levels in coming months being the 80% retracement of entire breather (₹ 1418-765)

Click here for full recommendation

Research view on more stocks

Pharmaceuticals company Ami Organics announced Q4FY24 & FY24 results:

  • Revenue from operations for Q4FY24 grew by 20.7% YoY and 35.2% QoQ to Rs 2,250 million
  • The gross margin for the quarter was at 40.0%. Gross margins were impacted due to change in product mix.
  • EBITDA for the quarter came at Rs 432 million up 5.9% YoY compared to Rs 408 million in Q4FY23 and up 62.8% QoQ compared to Rs 265 million in Q3FY24.
  • EBITDA margin for the quarter was at 19.2% as compared to 21.9% in Q4FY23 and 15.9% in Q3FY24. EBITDA margins contracted by 269bps YoY and grew by 326 bps sequentially.
  • Adjusted PAT for the quarter was Rs 260 million. Adjusted PAT margin for the quarter was 11.6%.

Commenting on results, Naresh Patel, Executive Chairman & Managing Director, Ami Organics, said: “I am pleased to share that we have been successful in navigating through the tough industry scenario to deliver an all-time high quarterly revenue from operations of Rs 225 crore. This represents a growth of 21% YoY and an exceptional 35% sequential growth. Our advanced pharmaceuticals business, grew strongly by 18% YoY and 47% QoQ while our specialty chemicals business grew robustly by 36% YoY during the quarter.

I am delighted to share that we have achieved the 'Gold Medal' accreditation from EcoVadis. Although we are in chemicals manufacturing industry, we remain steadfast on our sustainability goals propelled by an intensified focus on green chemistry and green initiatives. This commitment underscores our proactive approach to environmental responsibility and sustainability.

I am also thrilled to inform you that recently we have received grant of 3 process patents from The Patent Office, Government of India. Two of these three products are niche and complex in nature.

Overall, I believe that we have navigated industry challenges adeptly in FY24 and as we progress ahead with improved overall prospects for the industry, we firmly believe we will sustain our growth trajectory, targeting a revenue growth in range of 20-25% for the fiscal year FY25.”

Result PDF

View Other Company Results

Ami Organics Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt

Weakness (6)

  • Negative profit growth, promoters decreasing shareholding QoQ
  • MFs decreased their shareholding last quarter
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (2)

  • Promoter decreasing their shareholding
  • High PE (PE > 40)

Resistance and support

R1 1,331.4
R2 1,351.9
R3 1,377.2
Pivot

1,306.05

S1 1,285.6
S2 1,260.3
S3 1,239.8
EMA SMA
1,243.0
1,212.1
1,187.1
1,164.8
1,228.8
1,217.0
1,164.0
1,171.8
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
SAGEONE INVESTMENT ADVISORS LLP Bulk Purchase 2024-02-23 1075 250000 NSE
VAGHASIA CHETANKUMAR CHHAGANLAL Block Purchase 2023-12-27 1163.25 86000 NSE
DHWANI GIRISHKUMAR CHOVATIA Block Sell 2023-12-27 1163.25 86000 NSE
Name Category Shares
NARESHKUMAR RAMJIBHAI PATEL PROMOTER 11.36%
SHEETALBEN N PATEL PROMOTER 9.65%
VAGHASIA CHETANKUMAR CHHAGANLAL PROMOTER 8.45%
PARULBEN VAGHASIA PROMOTER 7.8%
BHANUBEN CHHAGANBHAI VAGHASIA PROMOTER 0.91%
CHHAGAN RAMJIBHAI VAGHASIA PROMOTER 0.9%

OUR RESEARCH VIEW

Investment recommendation
Call Date
16 May 2023
Entry Price 1,115.00
Target Price 1,290.00
Duration
3 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Ami Organics Ltd Stocks COMPARISON

Financials( in Cr) Ami Organics Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 1,310.95 1,520.95 1,574.80 4,564.50 1,078.95
% Change 1.15 0.33 0.64 -0.53 -2.76
Mcap Cr 4,939.66 364,926.86 127,144.16 121,173.33 108,567.62
Revenue TTM Cr 616.73 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 83.29 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 79.22 36.34 29.68 76.10 28.94
1 Year Return 0.84 54.15 60.91 30.94 102.68
ROCE 20.43 16.79 14.76 19.30 16.25
ROE 14.92 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 593.96 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,550.52 645.34
LAST 3M 105,892.14 -28,833.11
LAST 6M 178,978.26 -15,682.85
LAST 12M 290,242.45 102,068.56

Ami Organics Ltd Information

Stock PE (TTM)
79.22
Promoter Holding
39.07%
Book Value
205.1766
ROCE
20.43%
ROE
14.92%
Description
  • The Company was initially formed as a partnership firm in the name of "Ami Organics" with effect from 03 January 2004 at Surat, India. The firm converted into a private limited company under the Companies Act, 1956 under the name of "Ami Organics Private Limited" with a certificate of incorporation dated 12 June 2007. Subsequently, the Company was converted into a public limited company, following which the Company`s name was changed to "Ami Organics Limited", and a fresh certificate of incorporation was issued by RoC on 18 April 2018. The company is one of the leading research and development (R&D) driven manufacturers of specialty chemicals with varied end usage, focussed towards the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients (APIs) and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals, especially from the recent acquisition of the business of Gujarat Organics Limited (GOL). As per the F&S Report, the company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Pharma Intermediates which the company manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, antiinflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, commanding significant market share both in India and globally. The company`s Pharma Intermediates used for manufacturing of APIs and NCEs portfolio has expanded from over 425 products as of 31 March 2019, to over 450 products as of 31 March 2021. During the FY2021, Bonus shares were issued to the existing shareholders of the Company as on the record date of 31.03.2021 by issue of 2,10,00,000 Equity shares of face value of Rs. 10 each.The Bonus shares were allotted in the ratio of 2:1 i.e Two new equity shares for every one existing shares of the company. As on 31 March 2021,the company has one joint venture company,namely AMI Onco-Theranostics,LLC. During the month of September 2021,the company came out with an IPO which comprised a fresh issue of Rs 200 crore and an offer for sale of Rs 370 crore by shareholders,mopped up a total of Rs 570 crore through its public issue.The company will utilise the proceeds from fresh issue and pre-IPO placement for repaying debts and meeting working capital requirements.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India(NSE) on 14 September 2021.

Registered Address

Plot No 440/4 5&6, Road No 82/A GIDC Sachin, Surat, Gujarat, 394230

Tel : 91-261-2397193/91-7227977744
Email : cs:amiorganics.com
Website : http://www.amiorganics.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 543349
NSE Code : AMIORG
Book Closure Date (Month) : Sep
BSE Group : A
ISIN : INE00FF01017

FAQ’s on Ami Organics Ltd Shares

You can buy Ami Organics Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Ami Organics Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 18, 2024 03:57 PM the closing price of Ami Organics Ltd was Rs.1,310.95.

The latest PE ratio of Ami Organics Ltd as of Jun 18, 2024 03:57 PM is 79.22

The latest PB ratio of Ami Organics Ltd as of Jun 18, 2024 03:57 PM is 0.16

The 52-week high of Ami Organics Ltd share price is Rs. 1,388.95 while the 52-week low is Rs. 1,004.45

According to analyst recommendations, Ami Organics Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 18, 2024 03:57 PM, the market cap of Ami Organics Ltd stood at Rs. 4,939.66.

Download App

Download Our App

Play Store App Store
market app